A comparison between sublobar resection and stereotactic ablative radiotherapy (SABR) in the treatment of lung cancer is a trending topic. However, there is still a lack of strong randomized controlled trials on this subject. We believe that the National Cancer Registry can provide good insight into decision-making when comparing these two modalities of treatment.
No takes yet. Share an insight, caveat, or question.
Qsous et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: